Why the study?
Does acetazolamide improve myotonia in patients with myotonia congenita or paramyotonia congenita?
Population
9 patients with disorders having myotonia as the major problem
Comparison
Acetazolamide vs Baseline (before acetazolamide administration)
Design
Case_series
Authors
Loading...
May be considered for refractory myotonia; leaves open confirmation in randomized trials.
Does acetazolamide improve myotonia in patients with myotonia congenita or paramyotonia congenita?
Acetazolamide appears to be an effective treatment for reducing myotonia in patients with myotonia congenita and paramyotonia congenita.
Griggs et al. (1978) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: